High Vista Strategies LLC Alkermes Plc. Transaction History
High Vista Strategies LLC
- $230 Million
- Q1 2025
A detailed history of High Vista Strategies LLC transactions in Alkermes Plc. stock. As of the latest transaction made, High Vista Strategies LLC holds 70,762 shares of ALKS stock, worth $1.89 Million. This represents 1.01% of its overall portfolio holdings.
Number of Shares
70,762
Previous 54,446
29.97%
Holding current value
$1.89 Million
Previous $1.57 Million
49.27%
% of portfolio
1.01%
Previous 0.65%
Shares
2 transactions
Others Institutions Holding ALKS
# of Institutions
407Shares Held
176MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$777 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$486 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$315 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$214 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$184 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.39B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...